←
Kelly Chibale1,707 posts
Kelly Chibale avatar

Kelly Chibale

@Kelly_Chibale

Professor at @UCT_News; Neville Isdell Chair; Founder and Director of H3D research centre; Editor-In-Chief at ACS Medicinal Chemistry Letters.

◷ Joined August 2020▧ 140 Photos and videos
Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·14h

2024 Top-Read Article in @ACSPublications: A bispecific PSMA/GRPR heterodimer combines PSMA-617 and RM2, showing dual tumour targeting, enhanced uptake & promising PK properties in preclinical studies: doi.org/10.1021/acsmedchemle… Author: Christos Liolios (University of West Attica)

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Nov 12

2024 Top-Read Article in #ACSMedChemLett: Development of a Buchwald–Hartwig Amination for an Accelerated Library Synthesis of Cereblon Binders doi.org/10.1021/acsmedchemle… Corresponding author: Natalie Holmberg-Douglas (Bristol Myers Squibb) @ACSPublications

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Oct 7

2024 Top-Read Article in #ACSMedChemLett: Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability Can one simple metric help guide permeability optimisation? doi.org/10.1021/acsmedchemle… @ACSPublications #KellyChibale

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Oct 7

2024 Top-Read Article in #ACSMedChemLett: Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists Exploring new serotonergic chemical space: doi.org/10.1021/acsmedchemle… @ACSPublications #KellyChibale

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Oct 7

2024 Top-Read Article in #ACSMedChemLett: Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery Expanding the molecular glue toolbox: doi.org/10.1021/acsmedchemle… @ACSPublications #KellyChibale

ACS Publications Bio & Med Chem Content avatar
⟳ Kelly Chibale retweeted
ACS Publications Bio & Med Chem Content@ACSBioMed·Aug 22

Our editors are catalysts for scientific progress as active researchers at top institutions. With expertise and global reach, they champion original research that shapes the future. Join a community committed to advancing science and submit today: go.acs.org/ezq

Post attachmentPost attachmentPost attachmentPost attachment
Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Jun 25

In #ACSMedChemLett, Kim et al. report a modified version of an existing drug (nitazoxanide) that shows promise against hepatitis B. 1 compound worked better than the original & showed good oral absorption, stability & efficacy in animal studies: pubs.acs.org/doi/10.1021/acs… @ACSBioMed

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Jun 18

Clofibric acid has been repurposed as a new “guiding tag” for a cutting-edge drug strategy that destroys harmful proteins, opening a new route for designing smarter cancer and disease treatments: pubs.acs.org/doi/10.1021/acs… #ACSMedChemLett @ACSBioMed

Kelly Chibale avatar
Kelly Chibale@Kelly_Chibale·Jun 11

#ACSMedChemLett reports a greener, simpler way to make a new molecules that may fight bacteria. In early tests, bacteria did not develop resistance to one compound after many repeated exposures. @ACSBioMed pubs.acs.org/doi/10.1021/acs…

ACS Publications Bio & Med Chem Content avatar
⟳ Kelly Chibale retweeted
ACS Publications Bio & Med Chem Content@ACSBioMed·May 31

Don't forget to register for our upcoming webinar, where winners of the 2026 Portoghese Lectureship Award will be discussing 'Emerging Medicinal Chemistry Approaches to Targeting Disease Pathways’. 📅 June 3, 12:00PM EDT Register to attend: go.acs.org/eg0

Post attachment